Pine Valley Investments’s GSK GSK Stock Holding History

Pine Valley Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$649K	Sell	12,349 -498	-4%	-$26.3K	0.03%	361
2026 Q1	$711K	Sell	12,847 -13	-0.1%	-$704	0.03%	334
2025 Q4	$632K	Buy	12,860 +13	+0.1%	+$606	0.03%	334
2025 Q3	$556K	Sell	12,847 -20	-0.2%	-$781	0.03%	337
2025 Q2	$496K	Buy	12,867 +77	+0.6%	+$2.94K	0.03%	347
2025 Q1	$497K	Sell	12,790 -2,033	-14%	-$74.4K	0.03%	342
2024 Q4	$503K	Buy	14,823 +1,818	+14%	+$65.4K	0.03%	335
2024 Q3	$533K	Sell	13,005 -1,820	-12%	-$74.5K	0.03%	313
2024 Q2	$572K	Hold	14,825	–	–	0.04%	292
2024 Q1	$637K	Sell	14,825 -395	-3%	-$16.3K	0.04%	279
2023 Q4	$566K	Sell	15,220 -885	-5%	-$31.8K	0.04%	286
2023 Q3	$585K	Buy	16,105 +105	+0.7%	+$3.73K	0.05%	269
2023 Q2	$572K	Buy	+16,000	New	+$574K	0.06%	249

Other funds holding GSK

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Pine Valley Investments's GSK Position: Q2 2026 in Review

Pine Valley Investments reduced its GSK (GSK) stake by 3.9% in Q2 2026, selling an estimated $26.3K and leaving 12,349 shares worth $649K. The position accounts for 0.03% of the portfolio, ranked #361.

Pine Valley Investments first reported a position in GSK in Q2 2023 and has held it in 13 quarters since. The position peaked at $711K in Q1 2026. 542 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Pine Valley Investments held 12,349 shares of GSK worth $649K as of Q2 2026.
Pine Valley Investments sold 498 GSK shares in Q2 2026, an estimated $26.3K.
GSK made up 0.03% of Pine Valley Investments's portfolio in Q2 2026, its #361 holding.
Pine Valley Investments first reported a position in GSK in Q2 2023 and has held it in 13 quarters since.
Pine Valley Investments's GSK position peaked at $711K in Q1 2026.
542 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.